NOVATO, CA (Thursday, May 14, 2009) – Biosearch Technologies, Inc. (Biosearch) today announced that the company has responded to the swine influenza pandemic, also known as 2009 H1N1, by offering to the public the rapid custom synthesis of all research use only (RUO) oligonucleotide probes and primers composing the swine flu detection panel recently developed and disclosed by the CDC. According to the CDC protocol of real-time PCR for detecting swine influenza A/H1N1 (CDC REF. #I-007-05), which is available to the public at the World Health Organization’s website: http://www.who.int/csr/resources/publications/swineflu/realtimeptpcr/en/index.html, FAM-BHQ® probes are key components in the Swine Influenza Virus Real-time RT-PCR Detection Panel (Swine Flu Test Kit).

As the inventors of the BHQ® (Black Hole Quencher®) dye technology integral to the performance of the swine flu probes, Biosearch is putting all effort behind producing these probes and primers to ensure that laboratories around the world can reliably access these important reagents to amplify and probe for swine influenza. “In view of the seriousness, of the recent AH1N1 pandemic, Biosearch is devoting its considerable expertise and resources to the manufacture of influenza-related probes and primers,” comments Ron Cook, President and CEO of Biosearch Technologies, “And, in anticipation of future events of this kind, we are expanding our manufacturing infrastructure to allow ultra rapid scale up and delivery of any oligo component that may be required for assays of new subtypes.”

Biosearch will, upon customer request, prepare custom probes and primers for the following assays: InfA probe and primers to detect all universal strains of influenza A; swInfA probe and primers to detect all strains of swine influenza A; swH1 probe and primers to detect all strains of swine influenza H1; and RnaseP probe and primers as a form of positive control. If your research requires oligos besides swine flu probes and primers, those too, will be prepared upon request. All such probe and primers are available to the public for RUO purposes.

To view Biosearch Technologies’ offering of these important swine flu related reagents, please visit www.biosearchtech.com/swineflu.

About Biosearch Technologies, Inc.

Biosearch Technologies, Inc. is a privately held, ISO 9001:2008 certified and GMP compliant biotechnology company located in northern California. Founded in 1993, Biosearch is a leader in the design, development and manufacture of oligonucleotide-based tools to accelerate the discovery and application of genomic-based information. Products include novel fluorescent dyes (CAL Fluor®, Quasar® and Pulsar® dyes), versatile dark quenchers for DNA/RNA and Peptide FRET applications (Black Hole Quencher® dyes), a specialty line of DNA synthesis reagents and immunochemicals. Biosearch is also a leading supplier of a wide variety of custom-synthesized PCR probe formats for real-time, quantitative PCR applications.

In addition to basic R&D applications, Biosearch now leverages its demonstrated expertise in DNA synthesis to the custom synthesis of DNA probes and primers for a variety of molecular diagnostic applications. From bulk qualified probe and primer reagents to fully assembled and ready-to-inventory assays, Biosearch has extensive experience manufacturing DNA for RUO, pharmaceutical, diagnostic IVD, biotech, ag/bio, environmental and food testing, public health and biodefense sectors.

For additional information about Biosearch Technologies, Inc., contact info@biosearchtech.com or visit www.biosearchtech.com.